Gastric retention controlled drug delivery system
The present invention provides a gastric retention controlled drug delivery system comprising: (a) a controlled release core comprising a drug, a highly swellable polymer and a gas generating agent, said core being capable of swelling and achieving floatation rapidly while maintaining its physical integrity in gastrointestinal fluids for prolonged periods, and (b) a rapidly releasing coat composition comprising the same drug as in the core and pharmaceutically acceptable excipients, wherein the coating composition surrounds the core such that the system provides a biphasic release of the drug in gastrointestinal fluids.
1. A gastric retention controlled drug delivery system for once-a-day therapy comprising a core of baclofen and release rate controlling excipients, and a rapidly releasing coat composition comprising baclofen or its pharmaceutically acceptable salt and pharmaceutically acceptable excipients wherein the said system is adapted to release baclofen in a controlled manner so as to provide control over the plasma levels, such that the plasma levels of baclofen are within a desirable range over a 24-hour period for said once-a-day therapy.
2. A method of providing plasma concentration of baclofen effective for once a day therapy; said method comprising orally administering a gastric retention controlled drug delivery system comprising:
a gastroretentive core comprising baclofen or its pharmaceutically acceptable salt; and
a rapid releasing coat composition comprising baclofen or its pharmaceutically acceptable salts,
wherein the system provides a biphasic release of baclofen in the gastrointestinal fluids.
3. A method as claimed in claim 2 , wherein the gastroretentive core comprises of highly swellable polymer and a gas generating agent.
4. A method as claimed in claim 3 , wherein the highly swellable polymer is a mixture of superdisintegrant and a hydrophilic polymer.
5. A method as claimed in claim 4 , wherein the superdisintegrant used is selected from a group consisting of crosslinked polyvinyl pyrrolidone, crosslinked sodium carboxymethyl cellulose and sodium starch glycolate, and the hydrophilic polymer is selected from a group consisting of cellulose ethers such as hydroxy C 1-4 alkyl C 1-4 alkyl celluloses, carboxyalkyl celluloses, hydroxy C 1-4 alkyl celluloses, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropyl methylcellulose and mixtures thereof.
6. A method as claimed in claim 5 , wherein the sodium starch glycolate is used in an amount ranging from about 10% to about 40% by weight of the core.
7. A method as claimed in claim 5 , wherein the hydrophilic polymer is a high viscosity cellulose derivative having aqueous solution viscosity ranging from about 500 mPas to about 120,000 mPas for a 2% w/v aqueous solution.
8. A method as claimed in claim 7 , wherein the high viscosity cellulose derivative is hydroxyethyl cellulose having aqueous solution viscosity ranging from 9000 to 30,000 mPas for a 2% w/v aqueous solution.
9. A method as claimed in claim 8 , wherein the hydroxyethyl cellulose is used in an amount ranging from about 15% to about 30% by weight of the core.
10. A method as claimed in claim 5 , wherein the ratio of sodium starch glycolate to hydroxyethyl cellulose is in the range from about 4:6 to about 6:4.
11. A method as claimed in claim 3 , wherein the gas generating agent is selected from a group consisting of carbonates, bicarbonates, sulfites and mixtures thereof.
12. A method as claimed in claim 11 , wherein the gas generating agent further comprises an acid source selected from a group consisting of organic acids such as citric acid, malic acid, succinic acid, tartaric acid, fumaric acid, maleic acid, ascorbic acid, glutamic acid, or their salts, and mixtures thereof.
13. A method as claimed in claim 12 , wherein the gas generating agent used is sodium bicarbonate.
14. A method as claimed in claim 13 , wherein the sodium bicarbonate is used in an amount ranging from about 1% to about 15% by weight of the core.
15. A method as claimed in claim 2 , wherein the core comprises an osmotic agent.
16. A method as claimed in claim 15 , wherein the osmotic agent is used in an amount ranging from about 2% to about 40% by weight of the core.